Imagion Biosystems announces that Ms Jovanka Naumoska has resigned from her position as Company Secretary of Imagion Biosystems, effective today, 8 December 2020. Ms Naumoska wil remain on the Board as a Non-Executive Director.
The Company has appointed Mr. Geoff Hollis as Company Secretary, effective today. Mr. Hollis was recently appointed as the Company’s Chief Financial Officer.
Read the full announcement at ASX.
https://youtu.be/hThLkmpJPW0 EGM 13 November 2023 Video transcript: Welcome and thanks for joining us. Both those joining virtually and those in person. As the time is
Highlights: Announced preliminary performance of MagSense® HER2 Imaging Agent in phase 1 study after study closure (post quarter end) Entered a strategic partnership with Prestige
Earlier this month, Imagion announced our upcoming EGM meeting to be held on 13th November, along with several resolutions to be voted on by shareholders. Here, Imagion
We’re on a mission to make cancer more detectable.
Imagion Biosystems (IBX) is an innovative medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases.
Stay informed about our latest news and developments.
© Imagion Biosystems, Ltd. All Rights Reserved | Privacy Policy | Terms & Conditions | Careers | Corporate Governance
